Study: New GSK vaccine reduces ear infections

03/4/2006 | HealthDay News

Czech researchers say their study of GlaxoSmithKline's new vaccine for ear infections found it reduced problems by one-third among children who received it. Containing proteins from 11 different strains of the bacterium Streptococcus pneumoniae that also are attached to a protein from the infectious agent Haemophilus influenzae, the vaccine is said to protect against the two main causes of middle-ear infection.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
PacificSource
Boise, ID